Glaukos (GKOS) Long-Term Investments (2017 - 2026)
Glaukos (GKOS) reported Long-Term Investments of $19.8 million for Q1 2026, up 31.13% year-over-year from $15.1 million in Q1 2025, and up 1.54% on a QoQ basis from $19.5 million in Q4 2025.
Glaukos (GKOS) has 10 years of Long-Term Investments data on file, last reported at $19.8 million in Q1 2026.
- Quarterly Long-Term Investments rose 31.13% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.8 million (up 31.13% YoY) and the FY2025 annual result came in at $19.5 million, up 32.65% from the prior year.
- Long-Term Investments improved to $19.8 million in Q1 2026 per GKOS's latest filing, from $19.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $19.8 million in Q1 2026 and bottomed at $7.2 million in Q1 2022.
- The 5-year median for Long-Term Investments is $12.6 million (2024), against an average of $12.8 million.
- The widest annual swing landed in 2022, when Long-Term Investments climbed 11.76%; it then surged 42.31% in 2024.
- Tracing GKOS's Long-Term Investments over 5 years: stood at $8.4 million in 2022, then soared by 38.1% to $11.6 million in 2023, then rose by 26.72% to $14.7 million in 2024, then surged by 32.65% to $19.5 million in 2025, then climbed by 1.54% to $19.8 million in 2026.
- Per Business Quant, the three latest GKOS Long-Term Investments figures stand at $19.8 million (Q1 2026), $19.5 million (Q4 2025), and $18.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 19.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.80 Mn |
| Dec 31, 2025 | 19.50 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 17.20 Mn |
| Mar 31, 2025 | 15.10 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Sep 30, 2024 | 14.80 Mn |
| Jun 30, 2024 | 13.70 Mn |
| Mar 31, 2024 | 12.60 Mn |
| Dec 31, 2023 | 11.60 Mn |
| Sep 30, 2023 | 10.40 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Sep 30, 2022 | 7.60 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 7.20 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | 6.80 Mn |
| Jun 30, 2021 | 6.50 Mn |
| Mar 31, 2021 | 5.80 Mn |
| Dec 31, 2020 | 5.30 Mn |
| Sep 30, 2020 | 4.60 Mn |
| Mar 31, 2020 | 3.10 Mn |
| Dec 31, 2019 | 3.50 Mn |
| Sep 30, 2019 | 3.10 Mn |
| Jun 30, 2019 | 2.90 Mn |
| Mar 31, 2019 | 2.50 Mn |
| Dec 31, 2018 | 1.90 Mn |
| Sep 30, 2018 | 2.00 Mn |
| Jun 30, 2018 | 1.70 Mn |
| Mar 31, 2018 | 900,000.00 |
| Dec 31, 2017 | 700,000.00 |
| Sep 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 200,000.00 |